At the February 24, 2015 USTR hearing on Special 301, KEI asked to provide supplemental comments on R&D for the record, and KEI was separately asked by USTR to provide comments on online pharmacies, and by DHHS to comment on the relationship between emergencies and compulsory licensing. (The KEI page on Special 301 is here: /ustr/special301).
At the February 24, 2015 USTR hearing on Special 301, KEI asked to provide supplemental comments on R&D for the record, and KEI was separately asked by USTR to provide comments on online pharmacies, and by DHHS to comment on the relationship between emergencies and compulsory licensing. (The KEI page on Special 301 is here: /ustr/special301).
At the February 24, 2015 USTR hearing on Special 301, KEI asked to provide supplemental comments on R&D for the record, and KEI was separately asked by USTR to provide comments on online pharmacies, and by DHHS to comment on the relationship between emergencies and compulsory licensing. (The KEI page on Special 301 is here: /ustr/special301).
Attached are KEI’s February 6 comments to USTR on the 2015 Special 301.
Our 7 page submission begins with this:
Attached are KEI’s January 30, 2015 comments on the India IP Policy.
/wp-content/uploads/KEI_30Jan2015_Comments_India_IPR_Policy.pdf
This is how the comments begin:
Knowledge Ecology International (KEI) has reviewed the document entitled “National IPR Policy” prepared by the IPR Think Tank. The document is surprisingly lacking in several key areas. In particular:
Attached are:
1. The SEPTA the law suit.
2. A pessimistic 2011 OECD working paper on the weak competition remedies for excessive pricing in the United States.
3. A 2012 report on a 2011 OECD policy roundtable on excessive pricing
Below is a cleaned up version of the transcript, from my rambling intervention for KEI on the broadcasting treaty definitions.
Thank you, Mr. Chairman. My comments would be initially on the definitions.It is our position that it’s more appropriate to provide protection for free services that are traditionally provided by radio and television and less appropriate for pay services,
Broadcasters make sweeping demands on scope and rights in new WIPO treaty
To understand the negotiations this week at the WIPO SCCR 29, it is helpful to review an April 2014 document, endorsed by several broadcasting organizations.
The attached document* is a joint statement by 12 broadcasting organizations, on “THE OBJECTIVES, SPECIFIC SCOPE AND OBJECT OF THE PROPOSED WIPO BROADCASTERS’ TREATY”.
The new Medicines Patent Pool license with AbbVie: good news for children living with HIV
The Medicines Patent Pool (MPP) has signed a new license with AbbVie, to expand access to pediatric formulations of lopinavir (LPV) and ritonavir (r). The details of the licenses are available here:
NIH rulemaking on transparency of clinical trials
The NIH has a notice about a proposed rule that “clarifies and expands requirements for the submission of clinical trial registration and results information to the ClinicalTrials.gov database.” Comments are due on or before February 19, 2015. We may ask the NIH to consider expanding the trials registry to include more information on the economics of clinical trials.
Here is a link to the Regulations.Gov docket for the proposed rule:
http://www.regulations.gov/#!documentDetail;D=NIH-2011-0003-0003 Continue Reading